Abstract
2,3-Dihydroindoles are promising agents for the synthesis of new compounds with neuroprotective and antioxidant properties. Usually, these compounds are obtained by direct reduction of the corresponding indoles containing acceptor groups in the indole ring for its activation. In this work, we propose a synthetic strategy to obtain new 2,3-dihydroindole derivatives from the corresponding polyfunctional 2-oxindoles. Three methods were proposed for reduction of functional groups in the 2-oxindole and 2-chloroindole molecules using various boron hydrides. The possibility of chemoselective reduction of the nitrile group in the presence of an amide was shown. The proposed synthetic strategy can be used, for example, for the synthesis of new analogs of the endogenous hormone melatonin and other compounds with neuroprotective properties.
Funder
Russian Science Foundation
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference40 articles.
1. Melatonin—A pleiotropic, orchestrating regulator molecule;Hardeland;Prog. Neurobiol.,2011
2. Melatonin: Therapeutic and clinical utilization;Altun;Int. J. Clin. Pract.,2007
3. Therapeutic uses of melatonin and melatonin derivatives: A patent review (2012–2014);Rivara;Expert Opin. Ther. Pat.,2015
4. Chojnacki, C., Błasiak, J., Fichna, J., Chojnacki, J., and Popławski, T. Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis. Molecules, 2018. 23.
5. Talib, W.H. Melatonin and Cancer Hallmarks. Molecules, 2018. 23.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献